High Investigational Doses of Oral Semaglutide Safe and Efficacious for Inadequately Uncontrolled Diabetes
Vanita Aroda, MD, director of Diabetes Clinical Research at Brigham and Women’s Hospital, and colleagues report data from the latest study in the PIONEER clinical trial program that suggests higher doses of semaglutide are safe and efficacious for adults with type 2 diabetes who need additional glycemic control.
Read More...